Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.306 SEK | +4.26% | +5.70% | -24.91% |
03-26 | Transcript : Vivesto AB - Special Call | |
03-07 | Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial | CI |
Business Summary
Number of employees: 14
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 26 | 100.0 % | 1 | 100.0 % | -96.12% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
100.0
%
| - | - | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 66 | 22/01/23 |
Robert Maiorana
DFI | Director of Finance/CFO | 64 | 30/11/20 |
Heidi Ramstad
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/21 |
Johanna Röstin
LAW | General Counsel | 57 | 30/09/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 18/03/19 | |
Hege Hellstrom
BRD | Director/Board Member | 59 | 25/09/19 |
Pål Ryfors
BRD | Director/Board Member | 41 | 24/05/22 |
Roger Tell
BRD | Director/Board Member | 59 | 24/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 538,043,455 | 330,469,658 ( 61.42 %) | 0 | 61.42 % |
Company contact information
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.91% | 14.48M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- VIVE Stock
- Company Vivesto AB